Cited by 408Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension StudiesDialysis and Renal Disease Management

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Sympathetic Activation in Chronic Renal Failure

Schlaich, Markus P., Socratous, Flora, Hennebry, Sarah, Eikelis, Nina, Lambert, Elisabeth A., Straznicky, Nora, Esler, Murray D., Lambert, Gavin W.·2009·Journal of the American Society of Nephrology

DOI 10.1681/asn.2008040402

Open this paper in CoChat — free account

Abstract

The potential involvement of sympathetic overactivity has been neglected in this population despite accumulating experimental and clinical evidence suggesting a crucial role of sympathetic activation for both progression of renal failure and the high rate of cardiovascular events in patients with chronic kidney disease. The contribution of sympathetic neural mechanisms to the occurrence of cardiac arrhythmias, the development of hypertension, and the progression of heart failure are well established; however, the exact mechanisms contributing to heightened sympathetic tone in patients with chronic kidney disease are unclear. This review analyses potential mechanisms underlying sympathetic activation in chronic kidney disease, the range of adverse consequences associated with this activation, and potential therapeutic implications resulting from this relationship.

Integrity signals

Registry

Crossref · 10.1681/asn.2008040402

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,661
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Neural Control of Renal Function*
Kopp, U. C., & DiBona, G. F. (2020) · Reflex Control of the Circulation · doi:10.1201/9780367813338-17 · Cited by 1,126
Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
Herzog, C. A., Ma, J. Z., & Collins, A. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391203 · Cited by 881
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 811
Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
Coresh, J., Wei, G. L., McQuillan, G. M., Brancati, F., Levey, A. S., Jones, C. A., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 579
Preeclampsia — A State of Sympathetic Overactivity
Schobel, H. P., Fischer, T., Heusser, K., Geiger, H., & Schmieder, R. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611143352002 · Cited by 556
Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure
Reid, I. A. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.6.e763 · Cited by 553
Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy
Cice, G., Ferrara, L., D’Andrea, A., D’Isa, S., Benedetto, A. D., Cittadini, A., Russo, P. E., Golino, P., & Calabrò, R. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00241-9 · Cited by 534
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease
Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., et al. (2002) · Circulation · doi:10.1161/hc1102.105261 · Cited by 519
Sympathetic Augmentation in Hypertension
Schlaich, M. P., Lambert, É., Kaye, D. M., Krozowski, Z. S., Campbell, D. J., Lambert, G. W., Hastings, J., Aggarwal, A., & Esler, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000103160.35395.9e · Cited by 509
Self-citation
Sympathetic Nerve Activity in End-Stage Renal Disease
Hausberg, M., Kosch, M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., & Rahn, K. H. (2002) · Circulation · doi:10.1161/01.cir.0000034043.16664.96 · Cited by 493
SPLANCHNICECTOMY FOR ESSENTIAL HYPERTENSION
Smithwick, R. H. (1953) · JAMA · doi:10.1001/jama.1953.03690160001001 · Cited by 480
Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure
Xu, J., Li, G., Wang, P., Velázquez, H., Yao, X., Li, Y., Wu, Y., Peixoto, A. J., Crowley, S. T., & Désir, G. V. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24066 · Cited by 464
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459
Self-citation
Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure
Ligtenberg, G., Blankestijn, P. J., Oey, P. L., Klein, I. H. H. T., Dijkhorst-Oei, L.-T., Boomsma, F., Wieneke, G. H., van Huffelen, A. C., & Koomans, H. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401704 · Cited by 407
Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS)
Pisoni, R. L., Bragg‐Gresham, J. L., Young, E. W., Akizawa, T., Asano, Y., Locatelli, F., Bommer, J., Cruz, J. M., Kerr, P. G., Mendelssohn, D. C., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.023 · Cited by 390
Body Weight Reduction, Sympathetic Nerve Traffic, and Arterial Baroreflex in Obese Normotensive Humans
Grassi, G., Seravalle, G., Colombo, M., Bolla, G., Cattaneo, B. M., Cavagnini, F., & Mancia, G. (1998) · Circulation · doi:10.1161/01.cir.97.20.2037 · Cited by 364
Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure
Campese, V. M., & Kogosov, E. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.878 · Cited by 356
Peripheral Chemoreceptor Hypersensitivity
Ponikowski, P. P., Chua, T. P., Anker, S. D., Francis, D. P., Doehner, W., Banasiak, W., Poole-Wilson, P. A., Piepoli, M. F., & Coats, A. J. S. (2001) · Circulation · doi:10.1161/hc3101.093699 · Cited by 307
Cardiovascular Effects of Nitric Oxide in the Brain Stem Nuclei of Rats
Tseng, C., Liu, H.-Y., Lin, H., Ger, L., Tung, C., & Yen, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.36 · Cited by 257
Sympathetic Activity Is Increased in Polycystic Kidney Disease and Is Associated with Hypertension
Klein, I. H. H. T., Ligtenberg, G., Oey, P. L., Koomans, H. A., & Blankestijn, P. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112427 · Cited by 244
Baroreflex Control of Sympathetic Nerve Activity and Heart Rate in Obstructive Sleep Apnea
Narkiewicz, K., Pesek, C. A., Kato, M., Phillips, B. G., Davison, D. E., & Somers, V. K. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.1039 · Cited by 237
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
Tonelli, M. A., Bohm, C. J., Pandeya, S., Gill, J., Levin, A., & KIBERD, B. A. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.22070 · Cited by 215
Sympathetic Hyperactivity in Chronic Renal Failure
Koomans, H. A., Blankestijn, P. J., & Joles, J. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113320.57127.b9 · Cited by 202
Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase
Li, G., Xu, J., Wang, P., Velázquez, H., Li, Y., Wu, Y., & Désir, G. V. (2008) · Circulation · doi:10.1161/circulationaha.107.732032 · Cited by 193
Cardiovascular complications in renal failure.
Rostand, S. G., Brunzell, J. D., Cannon, R. O., & Victor, R. G. (1991) · Journal of the American Society of Nephrology · doi:10.1681/asn.v261053 · Cited by 191
Effects of Low Dose Sympathetic Inhibition on Glomerulosclerosis and Albuminuria in Subtotally Nephrectomized Rats
Amann, K., Rump, L. C., Simonaviciene, A., Oberhauser, V., Wessels, S., Orth, S. R., Groß, M.-L., KOCH, A., Bielenberg, G. W., van Kats, J. P., et al. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181469 · Cited by 190
Role of nitric oxide in the neural control of cardiovascular function
Zanzinger, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00085-1 · Cited by 174
Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat
Campese, V. M., Kogosov, E., & Koss, M. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90456-5 · Cited by 173
Increased Sympathetic Nerve Activity in Renovascular Hypertension
Johansson, M., Elam, M., Rundqvist, B., Eisenhofer, G., Herlitz, H., Lambert, G., & Friberg, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2537 · Cited by 172
Self-citation
Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure
Ye, S., Ozgur, B. M., & Campese, V. M. (1997) · Kidney International · doi:10.1038/ki.1997.103 · Cited by 167
Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.
Miyajima, E., Yamada, Y., Yoshida, Y., Matsukawa, T., Shionoiri, H., Tochikubo, O., & Ishii, M. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.1057 · Cited by 163
Renal and systemic nitric oxide synthesis in rats with renal mass reduction
Aiello, S., Noris, M., Todeschini, M., Zappella, S., Foglieni, C., Benigni, A., Corna, D., Zoja, C., Cavallotti, D., & Remuzzi, G. (1997) · Kidney International · doi:10.1038/ki.1997.317 · Cited by 155
Enalapril and Losartan Reduce Sympathetic Hyperactivity in Patients with Chronic Renal Failure
Klein, I. H. H. T., Ligtenberg, G., Oey, P. L., Koomans, H. A., & Blankestijn, P. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045049.72965.b7 · Cited by 150
The physiologic reserve in oxygen carrying capacity: studies in experimental hemodilution
Chapler, C. K., & Cain, S. M. (1986) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y86-002 · Cited by 147
Renal Sympathetic Nerve Responses to Tempol in Spontaneously Hypertensive Rats
Shokoji, T., Nishiyama, A., Fujisawa, Y., Hitomi, H., Kiyomoto, H., Takahashi, N., Kimura, S., Kohno, M., & Abe, Y. (2003) · Hypertension · doi:10.1161/01.hyp.0000049621.85474.cf · Cited by 147
Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions
Mailloux, L., & Haley, W. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70146-5 · Cited by 139
Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog.
Katholi, R. E., Whitlow, P. L., Hageman, G. R., & Woods, W. T. (1984) · PubMed · Cited by 136
Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat
Bennett, D., Koltzenburg, M., Priestley, J. V., Shelton, D. L., & McMahon, S. B. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00139.x · Cited by 133
Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy
Lazarus, J. M. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.133.6.1059 · Cited by 114
Lowering of Microalbuminuria in Diabetic Patients by a Sympathicoplegic Agent: Novel Approach to Prevent Progression of Diabetic Nephropathy?
STROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., & RITZ, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123602 · Cited by 112
Trophic Effect of Norepinephrine on Arterial Intima-Media and Adventitia Is Augmented by Injury and Mediated by Different α1-Adrenoceptor Subtypes
Zhang, H., & Faber, J. E. (2001) · Circulation Research · doi:10.1161/hh2101.098379 · Cited by 110
Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers
Amann, K., Koch, A., Hofstetter, J., Groß, M.-L., Haas, C. S., Orth, S. R., Ehmke, H., Rump, L. C., & Ritz, E. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00936.x · Cited by 106
Effect of chronic renal failure on nitric oxide metabolism
Vaziri, N. D. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27409 · Cited by 106
A Limited Renal Injury May Cause a Permanent Form of Neurogenic Hypertension
Ye, S., Gamburd, M., Mozayeni, P., Koss, M., & Campese, V. M. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00030-2 · Cited by 106
Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
Ye, S., Nosrati, S. N., & Campese, V. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119191 · Cited by 104
Familial Hyperkalemic Hypertension
Hadchouel, J., Delaloy, C., Faure, S., Achard, J., & Jeunemaı̂tre, X. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030314 · Cited by 102
Kidney and hypertension
Adamczak, M., Zeier, M., Dikow, R., & Ritz, E. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.28.x · Cited by 95
Moxonidine treatment of hypertensive patients with advanced renal failure
Vonend, O., Marsalek, P., Russ, H., Wulkow, R., Oberhauser, V., & Rump, L. C. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00021 · Cited by 91
Elevated plasma catecholamines in hypertensives with primary glomerular diseases.
Ishii, M., Ikeda, T., Takagi, M., Sugimoto, T., Atarashi, K., Igari, T., Uehara, Y., Matsuoka, H., Hirata, Y., Kimura, K., et al. (1983) · Hypertension · doi:10.1161/01.hyp.5.4.545 · Cited by 85
α1-Adrenoceptor stimulation directly induces growth of vascular wall in vivo
Erami, C., Zhang, H., Ho, J. G., French, D. M., & Faber, J. E. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00218.2002 · Cited by 82
Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure
Hering, D., Zdrojewski, Z., Król, E., Kára, T., Kucharska, W., Somers, V. K., Rutkowski, B., & Narkiewicz, K. (2006) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280102d92 · Cited by 82
Downregulation of Neuronal Nitric Oxide Synthase and Interleukin-1β Mediates Angiotensin II-Dependent Stimulation of Sympathetic Nerve Activity
Campese, V. M., Ye, S., & Zhong, H. (2002) · Hypertension · doi:10.1161/hy0202.102815 · Cited by 79
Effect of renal denervation on dynamic autoregulation of renal blood flow
DiBona, G. F., & Sawin, L. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00010.2004 · Cited by 71
Sympathetic Activity and Blood Pressure Pattern in Autosomal Dominant Polycystic Kidney Disease Hypertensives
Cerasola, G., Vecchi, M. L., Mulè, G., Cottone, S., Mangano, M. T., Andronico, G., Contorno, A., Parrino, I., Renda, F., & Pavone, G. (1998) · American Journal of Nephrology · doi:10.1159/000013382 · Cited by 68
Norepinephrine-related mechanism in hypertension accompanying renal failure
Schohn, D. C., Weidmann, P. U., Jahn, H. A., & Beretta-Piccoli, C. (1985) · Kidney International · doi:10.1038/ki.1985.203 · Cited by 67
Sensory denervation of the kidney attenuates renovascular hypertension in the rat
Wyss, J. M., Aboukarsh, N., & Oparil, S. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.1.h82 · Cited by 67
Central imidazoline (I1) receptors as targets of centrally acting antihypertensives
van Zwieten, P. A. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715020-00001 · Cited by 65
Altered norepinephrine turnover in the brown fat of rats with chronic renal failure.
Bigazzi, R., Kogosov, E., & Campese, V. M. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4111896 · Cited by 65
Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients
Frank, H., Heusser, K., Höffken, B., Huber, P., Schmieder, R. E., & Schobel, H. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00810.x · Cited by 61
Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats
Attia, D. M., Ni, Z., de Boer, P., Attia, M. A., Goldschmeding, R., Koomans, H. A., Vaziri, N. D., & Joles, J. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00313.x · Cited by 61
Neurogenic factors and hypertension in chronic renal failure.
Vm, C. (1997) · PubMed · Cited by 58
Endothelial cell dysfunction and nitric oxide synthase
Goligorsky, M. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00292.x · Cited by 54
The autonomic nervous system and cardiac arrhythmias
Esler, M. (1992) · Clinical Autonomic Research · doi:10.1007/bf01819669 · Cited by 48
Self-citation
Plasma Catecholamines and Autonomic Nervous System Function in Patients with Early Renal Insufficiency and Hypertension: Effect of Clonidine
Levitan, D., Massry, S. G., Romoff, M. S., & Campese, V. M. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183111 · Cited by 43
Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease
Beretta-Piccoli, C., Weidmann, P. U., Schiffl, H., Cottier, C., & Reubi, F. C. (1982) · Kidney International · doi:10.1038/ki.1982.169 · Cited by 43
Neural contribution to renal hypertension following acute renal artery stenosis in conscious rats.
Faber, J. E., & Brody, M. J. (1983) · Hypertension · doi:10.1161/01.hyp.5.2_pt_2.i155 · Cited by 42
Adenosine, a Metabolic Trigger of the Exercise Pressor Reflex in Humans
da Costa, F. A. A., Diedrich, A., Johnson, B., Sulur, P., Farley, G., & Biaggioni, I. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.917 · Cited by 38
Effects of imidazolines on noradrenaline release in rat isolated kidney
Böhmann, C., Schollmeyer, P. J., & Rump, L. C. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169827 · Cited by 38
Comparison between carvedilol and captopril in rats with partial ablation‐induced chronic renal failure
Brooks, D. P., Short, B. G., Cyronak, M. J., Contino, L. C., DiCristo, M., Wang, Y., & Ruffolo, R. R., Jr. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13610.x · Cited by 37
Increased Norepinephrine Secretion in Patients with the Nephrotic Syndrome and Normal Glomerular Filtration Rates: Evidence for Primary Sympathetic Activation
Rahman, N., Abraham, W. T., VanPutten, V., Hasbargen, J. A., & Schrier, R. W. (1993) · American Journal of Nephrology · doi:10.1159/000168631 · Cited by 32
Adenosine and renal sodium handling
Fransen, R., & Koomans, H. A. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v651491 · Cited by 31
Comparison of the Effects of an ACE Inhibitor and .ALPHA..BETA. Blocker on the Progression of Renal Failure with Left Ventricular Hypertrophy: Preliminary Report.
Suzuki, H., Moriwaki, K., Kanno, Y., Nakamoto, H., Okada, H., & Chen, X. (2001) · Hypertension Research · doi:10.1291/hypres.24.153 · Cited by 19
Carotid and aortic bodies in chronically anemic normotensive and spontaneously hypertensive rats
Habeck, J.-O., & Przybylski, J. (1989) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(89)90149-5 · Cited by 10
Dopaminergic control of prolactin and blood pressure.
García‐Robles, R., Ruilope, L. M., Hurtado, A., Rodicio, J. L., & Sancho, J. (1983) · Hypertension · doi:10.1161/01.hyp.5.1.155 · Cited by 9
The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension.
Karagiannis, A. I., Δούμα, Σ., Vogiatzis, K., Petidis, K., Doumas, M. N., Vyzantiadis, A., Efremidis, S. C., & Zamboulis, C. (1994) · PubMed · Cited by 6

Sorted by citations

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,794
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citation
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Calkins, H. G., Hindricks, G., Cappato, R., Kim, Y., Saad, E., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, A. J., et al. (2017) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,203
Sympathetic Nervous System Overactivity and Its Role in the Development of Cardiovascular Disease
Malpas, S. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00007.2009 · Cited by 696
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schäeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 728

See all 408

Authors: Schlaich, M. P., Socratous, F., Hennebry, S., Eikelis, N., Lambert, E. A., Straznicky, N., Esler, M. D., & Lambert, G. W.
Affiliations: Baker Heart and Diabetes Institute (AU)
Corresponding author: Schlaich, Markus P.
ORCID: Schlaich, Markus P.
Eikelis, Nina
Esler, Murray D.
Lambert, Gavin W.
Venue: Journal of the American Society of Nephrology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-05
Volume: 20
Issue: 5
Pages: 933-939
ISSN: 1046-6673 (ISSN-L)
DOI: 10.1681/asn.2008040402
OpenAlex: W2150333966
Cited by: 408
References: 77
Citations by year: 2025: 12 · 2024: 12 · 2023: 25 · 2022: 14 · 2021: 17 · 2020: 20 · 2019: 25 · 2018: 17 · 2017: 36 · 2016: 34 · 2015: 21 · 2014: 32 · 2013: 44 · 2012: 35
FWCI: 17.16
Type: journal article
Language: en
Open access: closed
Locations: Journal of the American Society of Nephrology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords: sympathetic activation, chronic kidney disease, sympathetic hyperactivity, cardiovascular events, cardiac arrhythmias, hypertension, heart failure, renal failure progression, therapeutic target
MeSH terms: Animals, Cardiovascular Diseases, Catecholamines, Clonidine, Debrisoquin, Disease Models, Animal, Efferent Pathways, Humans, Hypertension, Kidney, Kidney Failure, Chronic, Monoamine Oxidase, Nerve Fibers, Nitric Oxide, Norepinephrine, Sympathetic Nervous System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sympathetic Activation in Chronic Renal Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks